ATE447414T1 - Verwendung aktivierter polymere zur trennung von protein- und polypeptid-multimeren - Google Patents
Verwendung aktivierter polymere zur trennung von protein- und polypeptid-multimerenInfo
- Publication number
- ATE447414T1 ATE447414T1 AT06706962T AT06706962T ATE447414T1 AT E447414 T1 ATE447414 T1 AT E447414T1 AT 06706962 T AT06706962 T AT 06706962T AT 06706962 T AT06706962 T AT 06706962T AT E447414 T1 ATE447414 T1 AT E447414T1
- Authority
- AT
- Austria
- Prior art keywords
- separate protein
- activated polymers
- polypeptide multimers
- polypeptide
- separate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05003332 | 2005-02-16 | ||
| PCT/EP2006/001359 WO2006087178A1 (en) | 2005-02-16 | 2006-02-15 | Use of activated polymers for separation of protein and polypeptide multimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE447414T1 true ATE447414T1 (de) | 2009-11-15 |
Family
ID=36168573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06706962T ATE447414T1 (de) | 2005-02-16 | 2006-02-15 | Verwendung aktivierter polymere zur trennung von protein- und polypeptid-multimeren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080312411A1 (de) |
| EP (1) | EP1848458B1 (de) |
| JP (1) | JP2008530163A (de) |
| AT (1) | ATE447414T1 (de) |
| AU (2) | AU2006215823A1 (de) |
| CA (1) | CA2594666A1 (de) |
| DE (1) | DE602006010176D1 (de) |
| DK (1) | DK1848458T3 (de) |
| ES (1) | ES2335304T3 (de) |
| HR (1) | HRP20090594T1 (de) |
| SI (1) | SI1848458T1 (de) |
| WO (1) | WO2006087178A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5766118B2 (ja) * | 2008-09-11 | 2015-08-19 | ウェルズ ファーゴ バンク ナショナル アソシエイション | ポリマー性アルファ−ヒドロキシアルデヒドおよびケトン反応剤ならびに抱合方法 |
| US9315514B2 (en) | 2012-08-27 | 2016-04-19 | Rhodes Technologies | 1,3-dioxanomorphides and 1,3-dioxanocodides |
| ES2623262T3 (es) | 2012-12-14 | 2017-07-10 | Purdue Pharma Lp | Derivados de morfinano que contienen nitrógeno y el uso de los mismos |
| WO2014091297A1 (en) | 2012-12-14 | 2014-06-19 | Purdue Pharma L.P. | Spirocyclic morphinans and their use |
| EP2931724B1 (de) | 2012-12-14 | 2017-01-25 | Purdue Pharma LP | Pyridonmorphinananaloga und biologische wirkung auf opioidrezeptoren |
| WO2014102587A1 (en) | 2012-12-28 | 2014-07-03 | Purdue Pharma L.P. | 7,8-cyclicmorphinan analogs |
| US8946255B2 (en) | 2012-12-28 | 2015-02-03 | Purdue Pharma L.P. | Substituted morphinans and the use thereof |
| AU2013369037C1 (en) | 2012-12-31 | 2017-06-08 | Rhodes Technologies | Process for preparing 7beta-substituted 6alpha,14alpha -ethenomorphinans and 7beta-substituted 6alpha,14alpha-ethanomorphinans |
| WO2015097548A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 7-beta-alkyl analogs of orvinols |
| WO2015097545A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans |
| WO2015097546A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Propellane-based compounds and their use as opioid receptor modulators |
| WO2015097547A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 10-substituted morphinan hydantoins |
| EP3089978B1 (de) | 2013-12-30 | 2018-08-29 | Purdue Pharma L.P. | Pyridonsulfonmorphinan-analoga als opioidrezeptorliganden |
| ES2926580T3 (es) | 2016-12-23 | 2022-10-27 | Minoryx Therapeutics S L | Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma |
| AU2019224127B2 (en) | 2018-02-23 | 2021-12-09 | Rhodes Technologies | Novel opioid compounds and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312808A (en) * | 1989-11-22 | 1994-05-17 | Enzon, Inc. | Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| EP2295450B1 (de) * | 2000-09-29 | 2015-01-28 | Merck Sharp & Dohme Corp. | Pegyliertes interleukin 10 |
| CN101426511A (zh) * | 2001-06-22 | 2009-05-06 | 法马西亚公司 | 化学修饰的祖细胞生成素连接物 |
-
2006
- 2006-02-15 CA CA002594666A patent/CA2594666A1/en not_active Abandoned
- 2006-02-15 SI SI200630466T patent/SI1848458T1/sl unknown
- 2006-02-15 ES ES06706962T patent/ES2335304T3/es not_active Expired - Lifetime
- 2006-02-15 JP JP2007555522A patent/JP2008530163A/ja not_active Withdrawn
- 2006-02-15 DK DK06706962.5T patent/DK1848458T3/da active
- 2006-02-15 AU AU2006215823A patent/AU2006215823A1/en not_active Abandoned
- 2006-02-15 WO PCT/EP2006/001359 patent/WO2006087178A1/en not_active Ceased
- 2006-02-15 DE DE602006010176T patent/DE602006010176D1/de not_active Expired - Lifetime
- 2006-02-15 US US11/884,300 patent/US20080312411A1/en not_active Abandoned
- 2006-02-15 HR HR20090594T patent/HRP20090594T1/hr unknown
- 2006-02-15 AT AT06706962T patent/ATE447414T1/de active
- 2006-02-15 EP EP06706962A patent/EP1848458B1/de not_active Expired - Lifetime
-
2007
- 2007-11-27 AU AU2007237199A patent/AU2007237199A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20080312411A1 (en) | 2008-12-18 |
| DK1848458T3 (da) | 2010-02-01 |
| WO2006087178A1 (en) | 2006-08-24 |
| HRP20090594T1 (hr) | 2009-12-31 |
| EP1848458B1 (de) | 2009-11-04 |
| CA2594666A1 (en) | 2006-08-24 |
| ES2335304T3 (es) | 2010-03-24 |
| SI1848458T1 (sl) | 2010-01-29 |
| JP2008530163A (ja) | 2008-08-07 |
| AU2007237199A1 (en) | 2008-01-17 |
| EP1848458A1 (de) | 2007-10-31 |
| AU2006215823A1 (en) | 2006-08-24 |
| DE602006010176D1 (de) | 2009-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE447414T1 (de) | Verwendung aktivierter polymere zur trennung von protein- und polypeptid-multimeren | |
| ATE498412T1 (de) | System zur abgabe von flüchtigen stoffen | |
| EA201170242A1 (ru) | Модифицированные бычьи полипептиды g-csf и их применение | |
| ATE525033T1 (de) | Optische sonde zur abgabe von licht | |
| CY1119751T1 (el) | Υλικα και μεθοδοι για θεραπεια ή προληψη ασθενειων που σχετιζονται me her-3 | |
| ATE531374T1 (de) | Vorrichtung auf polymerbasis mit verzögerter freisetzung | |
| CY1112924T1 (el) | Κυτταροδιαπερατοι αναστολεις της jnk-σηματοδοτικης πορειας μεταγωγης | |
| WO2007104062A3 (en) | Compositions and methods based on peptide binding profiling | |
| BRPI0506679A (pt) | métodos de tratar osteoartrite com antagonistas de il-6 | |
| CR11504A (es) | Deteccion mejorada de la expresion de mage-a | |
| EA201270553A1 (ru) | Ингибиторы тирозинкиназы брутона | |
| EA201171494A1 (ru) | Миметики белка smac | |
| EA201000327A1 (ru) | Белок | |
| ATE506861T1 (de) | Molkenproteinträger zur abgabe von aktivsubstanzen | |
| DE602008002693D1 (de) | Vakzine-peptid-kombinationen gegen katzenallergie | |
| CY1120055T1 (el) | Αντικαρκινικη πρωτεϊνη συντηξης | |
| CY1119930T1 (el) | Λευκολεκτινες και χρησεις αυτων | |
| DE602005012555D1 (de) | Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon | |
| DE602007001103D1 (de) | Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2 | |
| CY1114618T1 (el) | Βιολογικα δραστικα πεπτιδια που περιεχουν καρβοξυτελικη αργινινη | |
| ATE484201T1 (de) | Verwendung von beta-cryptoxanthin | |
| ATE472317T1 (de) | Kosmetische verwendung von molkeproteinmizellen | |
| WO2009047513A3 (en) | Antagonists of kisspeptin and uses thereof | |
| DE602006008892D1 (de) | Kompaktes system zur verpackung von injizierbaren gungen | |
| DE602005027400D1 (de) | Il-22 zur behandlung von fettleibigkeit, diabetes, hyperlipidämie, hyperglykämie und insulinresistenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1848458 Country of ref document: EP |